Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results entities : Cytokinetics, incorporated save search
Cytokinetics Reports Fourth Quarter 2023 Financial Results
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -3.77%
H: 1.28%
C: -6.22%
financial results
Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
Published: 2024-02-13 (Crawled : 21:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 1.13%
H: 0.74%
C: -1.8%
results
Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Published: 2023-12-27 (Crawled : 12:30) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 61.12%
H: 13.81%
C: 13.29%
positive trial results
Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy
Published: 2023-12-26 (Crawled : 21:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 61.12%
H: 13.81%
C: 13.29%
topline trial results
Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND
Published: 2023-12-07 (Crawled : 12:30) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 0.06%
H: 6.42%
C: 4.12%
symposium international results
Cytokinetics Reports Third Quarter 2023 Financial Results
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.35%
H: 0.86%
C: 0.36%
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 2.34%
H: 3.75%
C: 2.45%
financial results
Cytokinetics to Announce Third Quarter Results on November 2, 2023
Published: 2023-10-23 (Crawled : 20:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 1.85%
H: 1.94%
C: -1.88%
results
Cytokinetics Reports Second Quarter 2023 Financial Results
Published: 2023-08-03 (Crawled : 20:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 0.91%
H: 9.32%
C: 3.75%
financial results
Cytokinetics to Announce Second Quarter Results on August 3, 2023
Published: 2023-07-27 (Crawled : 20:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 0.16%
H: 3.97%
C: 3.0%
results
Cytokinetics Reports First Quarter 2023 Financial Results
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 4.28%
H: 0.0%
C: -3.73%
financial results
Cytokinetics to Announce Fourth Quarter Results on March 1, 2023
Published: 2023-02-15 (Crawled : 14:20) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -0.86%
H: 5.81%
C: 3.84%
results
Cytokinetics Reports Fourth Quarter 2022 Financial Results
Published: 2023-03-01 (Crawled : 14:20) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -3.57%
H: 1.8%
C: -4.74%
financial results
Cytokinetics to Announce First Quarter Results on May 4, 2023
Published: 2023-04-20 (Crawled : 23:00) - biospace.com/
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -0.84%
H: 0.32%
C: -2.71%
results
Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session
Published: 2023-03-04 (Crawled : 16:20) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
| Email alert
Add to watchlist
cardiology positive results
Cytokinetics to Announce Third Quarter Results on November 3, 2022
Published: 2022-10-20 (Crawled : 23:00) - biospace.com/
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -0.11%
H: 2.7%
C: 0.64%
results
Cytokinetics Announces Additional Results From REDWOOD-HCM to Be Presented at the American Society of Echocardiography 33rd Annual Scientific Sessions
Published: 2022-06-03 (Crawled : 23:00) - biospace.com/
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -1.62%
H: 5.87%
C: 5.41%
sessions results
Cytokinetics to Announce First Quarter Results on May 4, 2022
Published: 2022-04-20 (Crawled : 21:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: 0.42%
H: 1.44%
C: -3.61%
results
Cytokinetics Announces Results From METEORIC-HF and Additional Data From GALACTIC-HF Presented at the American College of Cardiology 71st Annual Scientific Session
Published: 2022-04-03 (Crawled : 16:20) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
| Email alert
Add to watchlist
cardiology results
Cytokinetics Announces Results From Cohort 3 of Redwood-HCM Presented at American College of Cardiology 71st Annual Scientific Session
Published: 2022-04-02 (Crawled : 16:20) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
| Email alert
Add to watchlist
cardiology results
Cytokinetics Announces Receipt of Breakthrough Therapy Designation from FDA for AficamtenFDA Granted Designation for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy Based on Results of REDWOOD-HCM
Published: 2021-12-09 (Crawled : 13:00) - biospace.com/
CYTK | $67.49 0.73% 0.73% 1.5M
|
Health Technology
|
| O: -2.93%
H: 0.0%
C: 0.0%
treatment fda cardio granted therapy results breakthrough therapy designation
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.